Biosimilars Policy Overview: October 2022
October ushered in a number of policy updates, including the implementation of a Biosimilar Switching Policy, the European Union’s declaration that biosimilars are interchangeable, and the reauthorization of the Drug Fee Act. use of biosimilars. National policies The most recent policy news this month was the implementation of a biosimilar switching policy in Saskatchewan, Canada, …